3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Antabio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants ANT3310, Meropenem - Pharmacokinetics Study on Healthy Volunteers Adults | Phase 1 | Completed | Antabio | 26 | 2025-04-28 | 2025-10-02 |
| Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects ANT3310, Meropenem - Renal Impairment | Phase 1 | Completed | Antabio | 41 | 2024-07-19 | 2025-07-29 |
| FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects ANT3310, ANT3310-placebo, Meropenem - Healthy Volunteers | Phase 1 | Completed | Antabio | 72 | 2023-04-12 | 2024-03-15 |
Meropenem (3)
France (1) · Germany (1) · United States (1)
Christian Zwingelstein, PharmD (1) · J. Burr Ross, MD (1) · Sophie Hays, MD (1)